Among the tissue inhibitors of metalloproteinases, we determined a statistically significant downregulation of the gene TIMP4 (−11.2) in meningiomas and TIMP2 (−2.0) in astrocytomas. This evidence concerns the gene TIMP2 and astrocytoma (excluding glioblastoma).